NFT-21005-02607

5 vaccinations 9 coded responses 50 check-ins 8 free-text entries 4 call cases

Sex: Female
Age at first dose: 16-20
ZIP prefix: 496 / MI
Registered: 2021-02-09

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-09
Registered in v-safe
2021-02-09
Dose 1 — Pfizer-BioNTech
2021-02-09
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-02-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-02-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-12
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-02-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-14
Survey response — days 1–6 daily, dose 1
MedDRA: Polymenorrhoea — Feeling: Fair

Free text: Period started 2.5 weeks early (day or two after COVID shot)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-16
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-02-23
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-02
Dose 2 — Pfizer-BioNTech
2021-03-02
Health check-in — day 0, dose 2
Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-03
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-09
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-03-18
Survey response — day 14, dose 2
MedDRA: Abdominal pain upper, Condition aggravated, Pre-existing disease, Vomiting — Feeling: Good · Be unable to do your normal daily activities

Free text: I have had worsening gastroparesis symptoms (much more vomiting and stomach pain). It could be a coincidence, but thought I should write it down!

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-23
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-03-30
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-06
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-13
Survey response — day 42, dose 2
MedDRA: Condition aggravated, Impaired gastric emptying — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: worsening gastroparesis (may be completely a coincidence)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-13
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-01
Survey response — 3 months, dose 2
MedDRA: Lymphadenopathy — Feeling: Poor · Be unable to do your normal daily activities

Free text: MRI results: Mildly prominent lymph nodes within the suprahyoid neck. Mildly prominent probable lymph node within the superficial lobe of the right parotid is also noted, measuring up to 9 mm in short axis.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-08-24
Dose 3 — Pfizer-BioNTech
2021-08-25
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-08-26
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-08-27
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Muscle or body aches

Adult check-in
2021-08-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-08-29
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache

Adult check-in
2021-08-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-08-31
Health check-in — day 7, dose 3
Feeling: Good · Muscle or body aches

Adult check-in
2021-09-09
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-09-14
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-09-21
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2021-10-07
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2021-11-25
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-02-22
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-03-24
Dose 4 — Pfizer-BioNTech
2022-03-25
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-03-25
Call 1 — Left Voicemail
2022-03-26
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2022-03-27
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-03-28
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Headache

Adult check-in
2022-04-01
Health check-in — day 7, dose 4
Feeling: Good · Headache

Adult check-in
2022-04-07
Health check-in — day 14, dose 4
Feeling: Poor

Adult check-in
2022-04-14
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-04-23
Survey response — day 28, dose 4
MedDRA: COVID-19, Cough, Discharge — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Still have coughing and drainage from COVID.

MedDRA releases: 2024-11 · check-in free text available
2022-04-23
Report sent to call center — day 28, dose 4
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-25
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-04-28
Survey response — day 35, dose 4
MedDRA: Bronchitis, COVID-19, Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: post covid sinus infection and bronchitis

MedDRA releases: 2024-11 · check-in free text available
2022-04-28
Report sent to call center — day 35, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-02
Call 2 — Could Not Reach Participant
2022-05-05
Call 3 — Could Not Reach Participant
2022-06-23
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2022-09-09
Dose 5 — Pfizer-BioNTech
2022-09-11
Survey response — days 1–6 daily, dose 5
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2024-11 · check-in free text available
2022-09-16
Health check-in — day 7, dose 5
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-10-07
Survey response — day 28, dose 5
MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: COVID-negative cold

MedDRA releases: 2024-11 · check-in free text available
2023-03-10
Survey response — 6 months, dose 5
MedDRA: Escherichia infection, Norovirus infection, Shigella infection, Urinary tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-03-10
Report sent to call center — 6 months, dose 5
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2023-03-13
Call 1 — Left Voicemail
2023-03-13
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-09	Pfizer-BioNTech
2	2021-03-02	Pfizer-BioNTech
3	2021-08-24	Pfizer-BioNTech	No
4	2022-03-24	Pfizer-BioNTech	No
5	2022-09-09	Pfizer-BioNTech	No

Call center

4 call center cases

2 successful · 2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-14

Systemic reaction (other): Period started 2.5 weeks early (day or two after COVID shot)

Release 5 — day 14, dose 2

2021-03-18

Symptoms: I have had worsening gastroparesis symptoms (much more vomiting and stomach pain). It could be a coincidence, but thought I should write it down!

Release 7 — day 42, dose 2

2021-04-13

Symptoms: worsening gastroparesis (may be completely a coincidence)

Release 8 — 3 months, dose 2

2021-06-01

Symptoms: MRI results: Mildly prominent lymph nodes within the suprahyoid neck. Mildly prominent probable lymph node within the superficial lobe of the right parotid is also noted, measuring up to 9 mm in short axis.

Release 11 — day 28, dose 4

2022-04-23

Symptoms: Still have coughing and drainage from COVID.

Release 11 — day 35, dose 4

2022-04-28

Symptoms: post covid sinus infection and bronchitis

Release 12 — days 1–6 daily, dose 5

2022-09-11

Systemic reaction (other): Dizziness

Release 12 — day 28, dose 5

2022-10-07

Symptoms: COVID-negative cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain upper	✓	✓	✓
SD	Bronchitis	·	·	✓
SD	Condition aggravated	✓	✓	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Discharge	·	·	✓
SD	Escherichia infection	·	·	✓
SD	Impaired gastric emptying	✓	✓	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Nasopharyngitis	·	·	✓
SD	Norovirus infection	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Shigella infection	·	·	✓
SD	Sinusitis	·	·	✓
SD	Urinary tract infection	·	·	✓
SD	Vomiting	✓	✓	✓
SRO	Dizziness	·	·	✓
SRO	Polymenorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release